Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
1078
-
Total 13F shares, excl. options
-
113M
-
Shares change
-
-1.59M
-
Total reported value, excl. options
-
$31.7B
-
Value change
-
-$398M
-
Put/Call ratio
-
0.99
-
Number of buys
-
460
-
Number of sells
-
-492
-
Price
-
$279.75
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2021
1,259 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q1 2021.
BIOGEN INC. - Common Stock (BIIB) has 1,078 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 113M shares
of 147M outstanding shares and own 77.1% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (16.8M shares), VANGUARD GROUP INC (11.9M shares), STATE STREET CORP (6.67M shares), WELLINGTON MANAGEMENT GROUP LLP (5.9M shares), Clearbridge Investments, LLC (3.97M shares), JPMORGAN CHASE & CO (3.89M shares), GEODE CAPITAL MANAGEMENT, LLC (2.8M shares), Bank of New York Mellon Corp (2.18M shares), NORTHERN TRUST CORP (2.12M shares), and RENAISSANCE TECHNOLOGIES LLC (1.94M shares).
This table shows the top 1078 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.